Pivotal phase III trial of ALZ 801 in patients with Alzheimer's disease positive for e4 allele of the apolipoprotein E
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2016
At a glance
- Drugs ALZ 801 (Primary)
- Indications Alzheimer's disease
- Focus Registrational; Therapeutic Use
- Sponsors Alzheon
- 24 Oct 2016 Planned initiation date changed from 1 Jan 2016 to 1 Jan 2017, according to an Alzheon media release.
- 25 Jul 2016 According to an Alzheon media release, this trial is expected to start in early 2017.
- 09 Sep 2015 According to an Alzheon media release, this trial is expected to start in 2016.